Inventor · disambiguated record
Vangipuram S. Rangan
Also filed as: RANGAN VANGIPURAM · RANGAN VANGIPURAM S
7 granted patents·4 pending applications·34 citations·filing 2004–2024
81Inventor score
Top patents by PatentIndex Score
11 records- 0192US8258266B2IP-10 antibodies and their usesDESHPANDE SHRIKANT·Filed 2009·Granted Sep 4, 2012·28 cites·17 claims
- 0290US12077584B2Methods of treating HLA-E-expressing cancers by administering antibodies which bind human natural killer cell inhibitory receptor group 2A (NKG2A)BRISTOL MYERS SQUIBB CO·Filed 2022·Granted Sep 3, 2024·1 cites·76 claims
- 0388US11274150B2Anti-human natural killer cell inhibitory receptor group 2A protein (NKG2A) antibodiesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 15, 2022·2 cites·113 claims
- 0483US2025101100A1Anti-nkg2a antibodies and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0578US11981734B2Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A)BRISTOL MYERS SQUIBB CO·Filed 2022·Granted May 14, 2024·0 cites·163 claims
- 0674US8945546B2IP-10 antibodies and their usesDESHPANDE SHRIKANT·Filed 2012·Granted Feb 3, 2015·2 cites·21 claims
- 0773US9994633B2IP-10 antibodies and their usesSQUIBB & SONS LLC·Filed 2014·Granted Jun 12, 2018·1 cites·4 claims
- 0861US2025333487A1Activatable dual-anchored masked molecules and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0957US2005191293A1IP-10 antibodies and their usesFiled 2004·Application pending·0 cites
- 1042US2017326249A1Antibody-drug conjugate of an anti-glypican-3 antibody and a tubulysin analog, preparation and usesBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 1139US10279049B2Antibody-drug conjugates of tubulysin analogs with enhanced stabilityBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 7, 2019·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →